SMITH & NEPHEW Aktie

 

The future of fracture fixation with novel side-specific nails featuring variable angle locking technology...

Smith & Nephew PLC on Monday said it had hired Ajay Dhankar, ex-senior partner at Mckinsey & Co, to its executive board. The Watford, Hertfordshire-based......

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the appointment of Ajay Dhankhar, PhD, as Chief Corporate Development & Strategy Officer, effective today. Ajay will report to Chief Executive Officer Deepak Nath and join the Smith+Nephew Executive Committee. ...

SNN teams with Standard Health to launch the United Kingdom's first orthopedic ASC, aiming to boost surgical efficiency and drive growth....

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a strategic partnership with Standard Health www.standardhealth.co.uk to support the development of the first-ever Orthopaedic Ambulatory Surgery Centre in the UK. Based in Poole, Dorset, the new centre will offer NHS and private patients access to leading joint repair and replacement technology for conditions such as rotator cuff repair, ACL reconstruction, knee and hip replacements, and foot & ankle/hand & wrist procedures....

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of a new medial stabilized insert for its LEGION Total Knee System (TKS). Medial stabilized inserts are seeing a steep rise in popularity, growing from 4% of Total Knee Arthroplasty procedures in 2018 to 32% in 2023.1...

Smith & Nephew PLC - Watford, England-based medical equipment provider - Wins 10-year contracted worth up to $75 million from the US Department of Defense......

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

LONDON (dpa-AFX) - Medical technology company Smith+Nephew (SN.L, SNN) has been selected to provide its Renasys Touch Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year c......

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS◊ TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year* contract for up to $75 million by the U.S. Department of Defense (DoD) through the Defense Logistics Agency (DLA)....

LONDON (dpa-AFX) - Smith & Nephew plc (SNN), Wednesday encouraging results for its CARTIHEAL AGILI-C Cartilage Repair Implant for the treatment of knee cartilage defects.The recent multicentre ran......

The CARTIHEAL Implant will be featured at the Arthroscopy Association of North America Annual Meeting (AANA 2025) this week...

“CORI on Tour” will highlight the latest advancements in robotics-assisted surgery for hip and knee joint replacement...

Die Roadshow „CORI on Tour“ zeigt die neuesten Fortschritte in der robotergestützten Chirurgie für Knie- und Hüftgelenkersatz ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

The Smith & Nephew share price was marching higher today, topping the Footsie index in the process. Is this cheap UK stock worth considering? The post Here's why the Smith & Nephew share price jumped 7% in the FTSE 100 today! appeared first on The Motley Fool UK....

Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Smith & Nephew PLC shares climbed on Wednesday as it said it made a good start to 2025 as revenue increased.The Watford, England-based medical technology......

LONDON (dpa-AFX) - Global medical technology company Smith+Nephew (SNN, SN.L), on Wednesday, reported steady revenue growth in the first quarter of 2025 despite various market challenges. The comp......

HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging opportunities in the evolving healthcare landscape, announced it has entered into an exclusive private label distribution agreement (“Agreement”) with global medical technology company Smith+Nephew (LSE:SN, NYSE:SNN). Under the Agreement, Smith+Nephew will market and sell CENTRIO Platelet-Rich Plasma System, their own branded version of Nuo's underlying Aurix® System to the United States wound care market. Nuo will continue to be responsible for manufacturing the product.   The Aurix product brand sold separately by Nuo will remain in the market under Nuo's full control and will be fully available commercially subject to certain customer overlap conditions more fully addressed in the Agreement.  ...